Fluvoxamine maleate

DRUG3 trials

Sponsors

Solvay Pharmaceuticals, AbbVie

Conditions

Major Depressive DisorderObsessive Compulsive Disorder

Phase 3

A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive Disorder

CompletedNCT01933919

AbbVieObsessive Compulsive Disorder

Start: 2013-08-14End: 2016-07-01Updated: 2017-12-04

Phase 4

Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents

TerminatedNCT00352768

Solvay PharmaceuticalsObsessive Compulsive Disorder

Start: 2006-08-31End: 2009-04-30Updated: 2010-03-04

Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents

CompletedNCT00353028

Solvay PharmaceuticalsMajor Depressive Disorder

Start: 2006-10-31End: 2009-07-31Updated: 2010-03-04